[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transcatheter Aortic Valve Replacement (TAVR) Market Analysis and Forecast 2024-2030

April 2024 | 128 pages | ID: G88671299E38EN
APO Research

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

According to APO Research, The global Transcatheter Aortic Valve Replacement (TAVR) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.

East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.

In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.

Report Includes

This report presents an overview of global market for Transcatheter Aortic Valve Replacement (TAVR), market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Transcatheter Aortic Valve Replacement (TAVR), also provides the revenue of main regions and countries. Of the upcoming market potential for Transcatheter Aortic Valve Replacement (TAVR), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transcatheter Aortic Valve Replacement (TAVR) revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Transcatheter Aortic Valve Replacement (TAVR) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Transcatheter Aortic Valve Replacement (TAVR) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology and Suzhou Jiecheng Medical Technology Co., etc.

Transcatheter Aortic Valve Replacement (TAVR) segment by Company
  • Edwards Lifesciences
  • Medtronic
  • Abbott
  • Boston Scientific
  • Meril Life Sciences
  • Venus Medtech
  • Bracco (HLT)
  • JenaValve Technology
  • Suzhou Jiecheng Medical Technology Co.
  • Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) segment by Type
  • Transfemoral Approach
  • Transapical Approach
  • Others
Transcatheter Aortic Valve Replacement (TAVR) segment by Application
  • Aortic Stenosis
  • Aortic Regurgitation
  • Others
Transcatheter Aortic Valve Replacement (TAVR) segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcatheter Aortic Valve Replacement (TAVR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transcatheter Aortic Valve Replacement (TAVR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcatheter Aortic Valve Replacement (TAVR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Transcatheter Aortic Valve Replacement (TAVR) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcatheter Aortic Valve Replacement (TAVR) revenue, gross margin, and recent development, etc.

Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Transcatheter Aortic Valve Replacement (TAVR) Market by Type
  1.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type, 2019 VS 2023 VS 2030
  1.2.2 Transfemoral Approach
  1.2.3 Transapical Approach
  1.2.4 Others
1.3 Transcatheter Aortic Valve Replacement (TAVR) Market by Application
  1.3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application, 2019 VS 2023 VS 2030
  1.3.2 Aortic Stenosis
  1.3.3 Aortic Regurgitation
  1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET DYNAMICS

2.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
2.2 Transcatheter Aortic Valve Replacement (TAVR) Industry Drivers
2.3 Transcatheter Aortic Valve Replacement (TAVR) Industry Opportunities and Challenges
2.4 Transcatheter Aortic Valve Replacement (TAVR) Industry Restraints

3 GLOBAL GROWTH PERSPECTIVE

3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Perspective (2019-2030)
3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Growth Trends by Region
  3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region: 2019 VS 2023 VS 2030
  3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2019-2024)
  3.2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2025-2030)

4 COMPETITIVE LANDSCAPE BY PLAYERS

4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players
  4.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players (2019-2024)
  4.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2019-2024)
  4.1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Transcatheter Aortic Valve Replacement (TAVR) Key Players Headquarters & Area Served
4.4 Global Transcatheter Aortic Valve Replacement (TAVR) Players, Product Type & Application
4.5 Global Transcatheter Aortic Valve Replacement (TAVR) Players Commercialization Time
4.6 Market Competitive Analysis
  4.6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market CR5 and HHI
  4.6.2 Global Top 5 and 10 Transcatheter Aortic Valve Replacement (TAVR) Players Market Share by Revenue in 2023
  4.6.3 2023 Transcatheter Aortic Valve Replacement (TAVR) Tier 1, Tier 2, and Tier

5 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET SIZE BY TYPE

5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
5.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2019-2030)

6 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) MARKET SIZE BY APPLICATION

6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
6.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2019-2030)

7 COMPANY PROFILES

7.1 Edwards Lifesciences
  7.1.1 Edwards Lifesciences Comapny Information
  7.1.2 Edwards Lifesciences Business Overview
  7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.1.5 Edwards Lifesciences Recent Developments
7.2 Medtronic
  7.2.1 Medtronic Comapny Information
  7.2.2 Medtronic Business Overview
  7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.2.5 Medtronic Recent Developments
7.3 Abbott
  7.3.1 Abbott Comapny Information
  7.3.2 Abbott Business Overview
  7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.3.5 Abbott Recent Developments
7.4 Boston Scientific
  7.4.1 Boston Scientific Comapny Information
  7.4.2 Boston Scientific Business Overview
  7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.4.5 Boston Scientific Recent Developments
7.5 Meril Life Sciences
  7.5.1 Meril Life Sciences Comapny Information
  7.5.2 Meril Life Sciences Business Overview
  7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.5.5 Meril Life Sciences Recent Developments
7.6 Venus Medtech
  7.6.1 Venus Medtech Comapny Information
  7.6.2 Venus Medtech Business Overview
  7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.6.5 Venus Medtech Recent Developments
7.7 Bracco (HLT)
  7.7.1 Bracco (HLT) Comapny Information
  7.7.2 Bracco (HLT) Business Overview
  7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.7.5 Bracco (HLT) Recent Developments
7.8 JenaValve Technology
  7.8.1 JenaValve Technology Comapny Information
  7.8.2 JenaValve Technology Business Overview
  7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.8.5 JenaValve Technology Recent Developments
7.9 Suzhou Jiecheng Medical Technology Co.
  7.9.1 Suzhou Jiecheng Medical Technology Co. Comapny Information
  7.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
  7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
7.10 Peijia Medical
  7.10.1 Peijia Medical Comapny Information
  7.10.2 Peijia Medical Business Overview
  7.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue and Gross Margin (2019-2024)
  7.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
  7.10.5 Peijia Medical Recent Developments

8 NORTH AMERICA

8.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue (2019-2030)
8.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
  8.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)
  8.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2025-2030)
8.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2019-2030)
8.4 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
  8.4.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)
  8.4.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2025-2030)
8.5 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2019-2030)
8.6 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  8.6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019 VS 2023 VS 2030)
  8.6.2 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024)
  8.6.3 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030)
  8.6.4 U.S.
  8.6.5 Canada

9 EUROPE

9.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue (2019-2030)
9.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
  9.2.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)
  9.2.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2025-2030)
9.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2019-2030)
9.4 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
  9.4.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)
  9.4.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2025-2030)
9.5 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2019-2030)
9.6 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  9.6.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019 VS 2023 VS 2030)
  9.6.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024)
  9.6.3 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030)
  9.6.4 Germany
  9.6.5 France
  9.6.6 U.K.
  9.6.7 Italy
  9.6.8 Russia

10 CHINA

10.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue (2019-2030)
10.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
  10.2.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)
  10.2.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2025-2030)
10.3 China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2019-2030)
10.4 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
  10.4.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)
  10.4.2 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2025-2030)
10.5 China Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2019-2030)

11 ASIA (EXCLUDING CHINA)

11.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue (2019-2030)
11.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
  11.2.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)
  11.2.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2025-2030)
11.3 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2019-2030)
11.4 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
  11.4.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)
  11.4.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2025-2030)
11.5 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2019-2030)
11.6 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  11.6.1 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019 VS 2023 VS 2030)
  11.6.2 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024)
  11.6.3 Asia Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030)
  11.6.4 Japan
  11.6.5 South Korea
  11.6.6 India
  11.6.7 Australia
  11.6.8 China Taiwan
  11.6.9 Southeast Asia

12 MIDDLE EAST, AFRICA, LATIN AMERICA

12.1 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue (2019-2030)
12.2 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2030)
  12.2.1 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2019-2024)
  12.2.2 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Type (2025-2030)
12.3 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Type (2019-2030)
12.4 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2030)
  12.4.1 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2019-2024)
  12.4.2 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Application (2025-2030)
12.5 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Application (2019-2030)
12.6 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country
  12.6.1 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019 VS 2023 VS 2030)
  12.6.2 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2019-2024)
  12.6.3 MEALA Transcatheter Aortic Valve Replacement (TAVR) Revenue by Country (2025-2030)
  12.6.4 Mexico
  12.6.5 Brazil
  12.6.6 Israel
  12.6.7 Argentina
  12.6.8 Colombia
  12.6.9 Turkey
  12.6.10 Saudi Arabia
  12.6.11 UAE

13 CONCLUDING INSIGHTS

14 APPENDIX

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
  14.5.1 Secondary Sources
  14.5.2 Primary Sources
14.6 Disclaimer


More Publications